Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 25743 [2013-10360]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 85 / Thursday, May 2, 2013 / Notices
Ron A. Otten,
Director, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2013–10403 Filed 5–1–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Member Conflict Review,
Program Announcement (PA) 07–318,
initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 1:00 p.m.–2:00 p.m., June
20, 2013 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Member Conflict Review, PA
07–318.’’
Contact Person for More Information: Joan
Karr, Ph.D., Scientific Review Officer, 2400
Executive Parkway, Mailstop E20, Atlanta,
Georgia 30345, Telephone: (404) 498–2506.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–10360 Filed 5–1–13; 8:45 am]
BILLING CODE 4163–18–P
sroberts on DSK5SPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
VerDate Mar<15>2010
16:50 May 01, 2013
Jkt 229001
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 78 FR 19711, dated
April 2, 2013) is amended to consolidate
the Office of the Chief Financial Officer
and the Financial Management Office,
Office of the Chief Operating Officer,
Centers for Disease Control and
Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows: Delete in its entirety the titles
and functional statements for the Office
of the Chief Financial Officer (CAJ1P)
and the Financial Management Office
(CAJE) insert the following:
Office of the Chief Financial Officer
(CAJE). The Office of the Chief Financial
Officer (OCF0) ensures that the Centers
for Disease Control and Prevention
(CDC) and the Agency for Toxic
Substances and Disease Registry
(ATSDR) accomplish their public health
mission through agency-wide fiscal
accountability and oversight.
Office of the Director (CAJE1). The
OCFO Office of the Director provides
leadership and coordination in the
development and administration of the
CDC’s financial management policies,
overseeing the Office of Finance and
Accounting and the Office of Budget.
Specifically, the OCFO: (1) Manages the
financial risk of the agency, (2) provides
leadership and advice on matters of
budget formulation, budget and
performance integration, and
Congressional appropriations for CDC
and ATSDR; (3) collaborates with the
Agency’s senior leadership in the
development and implementation of
long-range, strategic program and
financial plans; (4) provides oversight of
the agency’s financial activities and
accounting practices; (5) performs
reviews and training in high risk areas
for both the Agency and the Department
where there appears to be fiscal
vulnerabilities; (6) provides expertise in
interpreting appropriations law issues
and financial policy matters; (7) advises
and assists the CDC Director, the Chief
Operating Officer, and other key agency
officials—both in program and business
service offices—on all fiscal aspects of
the agency; (8) participates in budget
reviews and hearings; (9) manages
CDC’s system of internal budgetary
planning and control of funds; (10)
develops and implements CDC-wide
budgetary, accounting, and fiscal
systems and procedures and prepares
financial reports; (11) conducts CDCwide manpower management (including
productivity measurement) activities;
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
25743
(12) serves as the focal point for
domestic and international travel
policy, procedures and interpretation;
(13) provides legislation reference
services; (14) analyzes data and makes
recommendations to assure effective
safeguards are in place to prevent fraud,
waste and abuse; (15) assists in
identifying or conducting special
financial management training
programs; (16) maintains liaison with
the Department of Health and Human
Services (DHHS), Office of Management
and Budget (OMB), Congress, and other
government organizations on financial
management matters; and (17) provides
support for public health by ensuring
that appropriated funds provided to the
agency are utilized, in compliance with
Congressional mandate, for the sole
purpose of preventing and controlling
infectious diseases domestically and
globally.
Office of Management Services
(CAJE13). (1) Collaborates and
maintains liaison with CDC
management officials to monitor and
address priority issues of concern to
CDC leadership; (2) manages the
OCFO’s operational budget processes,
including planning, execution, and
monitoring; (3) manages OCFO’s
acquisition processes; (4) analyzes and
provides recommendations on workload
efficiency and resource utilization; (5)
provides direction, strategy, analysis,
operational support, and
recommendations in matters concerning
organizational performance and
management services within OCFO; (6)
coordinates the development of, and
maintains, strategic management and
performance measurement tools within
OCFO; (7) monitors OCFO
organizational performance and
provides recommendations on
performance improvement; (8) provides
management, oversight, and
administrative support for OCFO service
desk operations; (9) provides direction,
strategy, analysis, and operational
support in all aspects of OCFO’s human
resources operations; (10) provides
leading practices in government
financial management practices to
OCFO; (11) develops, implements, and
manages recruiting, hiring, retention,
and succession strategies; (12)
coordinates creation and
implementation of operating standards/
procedures and processes, and monitors
compliance; (13) develops, implements,
and manages the professional
development strategy and plan for
OCFO; (14) develops and implements
OCFO’s communication strategy and
plan; (15) manages the development and
communication of financial
E:\FR\FM\02MYN1.SGM
02MYN1
]]>Agencies
[Federal Register Volume 78, Number 85 (Thursday, May 2, 2013)]
[Notices]
[Page 25743]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-10360]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Member Conflict Review,
Program Announcement (PA) 07-318, initial review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time and Date: 1:00 p.m.-2:00 p.m., June 20, 2013 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the initial
review, discussion, and evaluation of applications received in
response to ``Member Conflict Review, PA 07-318.''
Contact Person for More Information: Joan Karr, Ph.D.,
Scientific Review Officer, 2400 Executive Parkway, Mailstop E20,
Atlanta, Georgia 30345, Telephone: (404) 498-2506.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2013-10360 Filed 5-1-13; 8:45 am]
BILLING CODE 4163-18-P
